The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 05, 2023

Filed:

Dec. 15, 2020
Applicant:

Twist Bioscience Corporation, South San Francisco, CA (US);

Inventors:

Eugene P. Marsh, El Granada, CA (US);

Pierre F. Indermuhle, Berkeley, CA (US);

Bill James Peck, Santa Clara, CA (US);

Assignee:

Twist Bioscience Corporation, South San Francisco, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
B01J 19/00 (2006.01);
U.S. Cl.
CPC ...
B01J 19/0046 (2013.01); B01J 2219/00317 (2013.01); B01J 2219/00378 (2013.01); B01J 2219/00509 (2013.01); B01J 2219/00533 (2013.01); B01J 2219/00596 (2013.01); B01J 2219/00637 (2013.01); B01J 2219/00653 (2013.01); B01J 2219/00659 (2013.01); B01J 2219/00662 (2013.01); B01J 2219/00716 (2013.01); B01J 2219/00722 (2013.01);
Abstract

Defined sequence RNA synthesis by 3'→5′ direction is now well established and currently in use for synthesis and development of vast variety of therapeutic grade RNA and Si RNA etc. A number of such synthetic RNA requires a modification or labeling of 3′-end of an oligonucleotide. The synthesis of 3′-end modified RNA requiring lipophilic, long chain ligands or chromophores, using 3′→5′ synthesis methodology is challenging, requires corresponding solid support and generally results in low coupling efficiency and lower purity of the final oligonucleotide in general because of large amount of truncated sequences containing desired hydrophobic modification. We have approached this problem by developing reverse RNA monomer phosphoramidites for RNA synthesis in 5′→3′-direction. They lead to very clean oligonucleotide synthesis allowing for introduction of various modifications at the 3′-end.


Find Patent Forward Citations

Loading…